About admin

This author has not yet filled in any details.
So far admin has created 40 entries.

EVENT – Going Live: Implementation of the Disclosure Code

January 29th 2015 - Hilton, Rotterdam - 9.30-13.15

This event is part of EFPIA's Responsible Transparency initiative, a public information campaign launched to boost pharmaceutical industry preparedness with complying to new disclosure rules for certain financial and other transfers of value with healthcare professionals and organisations. This event will inform the public on the progress of disclosure on a European and member state level.
  • Permalink Gallery

    Financial Transparency Can Help Put Greece Back on the Path to Growth

Financial Transparency Can Help Put Greece Back on the Path to Growth

The Disclosure Code represents a contribution from the industry to the modernisation and reform needed to restore the country’s economy

Learning the Lessons From the US on Disclosure

By Richard Bergström

The US Open Payments database got off to a less than happy start. EFPIA will tap into this experience to inform implementation of the code on disclosure in Europe, says Richard Bergström, Director General of EFPIA
  • Permalink Gallery

    Transparency Message Goes Out to Healthcare Professionals Across Greece

Transparency Message Goes Out to Healthcare Professionals Across Greece

Greece’s industry body, the Hellenic Association of Pharmaceutical Companies (SFEE) launched its transparency code to the key stakeholders at an event in Athens, following this up with Disclosure Code Month, a national awareness campaign to explain the objectives of the code to healthcare professionals across the country.
  • Permalink Gallery

    Collaboration is at the Heart of Personalised Medicine – and This Must be Underpinned by Trust

Collaboration is at the Heart of Personalised Medicine – and This Must be Underpinned by Trust

by Carin Smand

Translating the basic science of genomics into medical innovation in the form of personalised medicines requires a high level of interchange between healthcare professionals and the industry. It is critical that these relationships are based on trust and a mutual understanding, says Carin Smand, Managing Director of the European Haematology Association.

Pharma and Transparency: Actions Speak Louder than Words

by Andrew Powrie-Smith

ABPI director Andrew Powrie-Smith says our responsibility to patients and society extends beyond the sale of medicines

Cloudy Outlook as Sun Rises on Open Payments

The US database disclosing transfers of value from pharma and medical technology companies to doctors went live at the end of September with details of 4.4 million transactions. But there are complaints it has not delivered transparency
  • Permalink Gallery

    Interview with Tim McGuire, Director, Global Health Care Professional Reporting, Eli Lilly & Company

Interview with Tim McGuire, Director, Global Health Care Professional Reporting, Eli Lilly & Company

by Tim McGuire

The voluntary disclosure of financial interactions between the pharmaceutical industry and health care professionals is another example of the continuous evolution of the pharmaceutical industry, says Tim McGuire, Director, Global Health Care Professional Reporting, Eli Lilly & Company.
  • Permalink Gallery

    Germany reports progress in implementing financial disclosure rules

Germany reports progress in implementing financial disclosure rules

by Holger Diener

Over the past ten years pharmaceutical companies in Germany have proactively responded to the general trend towards greater transparency that has swept across public and corporate life. This puts the industry on the front foot in implementing the new financial disclosure code, says Dr Holger Diener, Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry

Pharma cannot develop drugs in an office

by Professor Martine Piccart

The industry simply does not have the expertise to develop the best drugs on its own. Companies must have access to clinical specialists – and the general public needs to understand the importance of this unique interaction between pharma and cancer experts, says Professor Martine Piccart, President of the European Cancer Organisation, ECCO